Elizabeth Holmes returns to the spotlight as explosive documentary reopens Theranos scandal

Elizabeth Holmes, the disgraced founder of Theranos, continues to attract widespread attention as a new documentary revisits the scandal that destroyed her reputation and exposed the risks of Silicon Valley’s promises.

The documentary, You Can See Everything, directed by Nathan Fielder and Lance Oppenheim, offers an intimate look at Holmes, her partner Billy Evans and their two young children shortly before she entered prison in 2023.

Holmes once emerged as a celebrated technology entrepreneur, promoting Theranos as a revolutionary healthcare company capable of conducting medical tests using just a tiny drop of blood. Her ambition and distinctive public image made her one of Silicon Valley’s most recognisable figures.

However, the company’s claims collapsed after investigations revealed serious problems with its blood-testing technology, including unreliable results. Holmes was subsequently convicted of defrauding investors and began serving her prison sentence in May 2023.

The new film explores Holmes’ continued insistence that she was wrongfully accused. In conversations with Fielder, she maintains that she never lied and portrays herself as a victim of public misunderstanding. Her statements leave the filmmakers and viewers confronting questions about accountability, credibility and the gap between public image and established facts.

Rather than offering straightforward answers, the documentary examines the complicated relationship between personal narratives and public perception. Its unconventional approach has attracted significant attention, with audiences and critics discussing its unusual portrayal of a convicted fraudster who continues to challenge the allegations against her.

Holmes’ story has already inspired documentaries, podcasts and television dramas, including The Dropout, in which Amanda Seyfried portrayed her in an award-winning performance.

Her continued public profile also reflects broader concerns about the technology industry, where ambitious claims and charismatic leadership can attract enormous investment before products are fully proven. In Theranos’ case, the consequences extended beyond investors, raising serious questions about the reliability of medical testing and the importance of patient safety.

The documentary’s release renews interest in Holmes’ legacy while leaving audiences to consider how ambition, reputation and denial can shape one of the most widely discussed corporate scandals of recent years.